Viewing Study NCT03276468


Ignite Creation Date: 2025-12-24 @ 5:39 PM
Ignite Modification Date: 2026-01-03 @ 7:16 PM
Study NCT ID: NCT03276468
Status: COMPLETED
Last Update Posted: 2023-01-10
First Post: 2017-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of Atezolizumab-Venetoclax-Obinutuzumab Combination in Relapse/Refractory Lymphomas
Sponsor: The Lymphoma Academic Research Organisation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module